Global Oncology Academy

Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALL
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
- Ryan Quigley
- Amanda Winters, MD, PhD
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
0.25 credits
- Benjamin Levy, MD
0.25 credits
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALL
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
- Charles Turck, PharmD, BCPS, BCCCP
- Lena Winestone, MD, MSHP
A New Era of Hope in Non-Small Cell Lung Cancer Care
A New Era of Hope in Non-Small Cell Lung Cancer Care
Project Oncology®
A New Era of Hope in Non-Small Cell Lung Cancer Care
- Geoffrey Oxnard, MD
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
- Geoffrey Oxnard, MD
Integrating Molecular Testing into NSCLC Care
Integrating Molecular Testing into NSCLC Care
Project Oncology®
Integrating Molecular Testing into NSCLC Care
- Geoffrey Oxnard, MD
Cosibelimab Delivers Durable Responses in Advanced CSCC
Cosibelimab Delivers Durable Responses in Advanced CSCC
Project Oncology®
Cosibelimab Delivers Durable Responses in Advanced CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Project Oncology®
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC

Medical News

Medical News
Microglial Fructose Metabolism and Immune Suppression in Glioblastoma
03/19/2026
Read more
Medical News
Clinical AI in Radiology: Translational Tools, Deployment, and Workflow Themes
03/16/2026
Read more
Medical News
Gut Microbiome and Checkpoint Immunotherapy: Reporting Recent Synthesis
03/11/2026
Read more
Medical News
ProstACT Part 1: TLX591-Tx Safety, Dosimetry, and Implications for Part 2
03/11/2026
Read more

See more news

CME/CE

Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
1.00 credit
- Ryan D. Cassaday, MD
- Daniel J. DeAngelo, MD, PhD
1.00 credit
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
MinuteCE®
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit
All Sides of the Joint: Integrated TGCT Care Across Specialties
All Sides of the Joint: Integrated TGCT Care Across Specialties
MinuteCE®
All Sides of the Joint: Integrated TGCT Care Across Specialties
1.00 program credit
- A.J. Gelderblom, MD, PhD
- Michiel van de Sande, MD, PhD
- Chelsea Cole, MD
1.00 program credit
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
MinuteCE®
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit

Clinical Practice

How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Project Oncology®
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
- Alexandria May, PharmD, BCPS
- Sunnie Kim, MD
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Project Oncology®
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
- Charles Turck, PharmD, BCPS, BCCCP
- Kelly McCann, MD, PhD
- Gregory Vidal, MD, PhD
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
AudioAbstracts
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
- Ryan Quigley
Smarter Screening for Non-Small Cell Lung Cancer
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®
Smarter Screening for Non-Small Cell Lung Cancer
- Jobelle Baldonado, MD

Programs

Updates in AML Care: Evolving ASH Guidelines for Older Adults
Updates in AML Care: Evolving ASH Guidelines for Older Adults
On the Frontlines of AML/ALL
Updates in AML Care: Evolving ASH Guidelines for Older Adults
- Shelina Ramnarine, PhD
- Mikkael A. Sekeres, MD, MS
Understanding the Growing Burden of Early-Onset CRC
Understanding the Growing Burden of Early-Onset CRC
On the Frontlines of Colorectal Cancer
Understanding the Growing Burden of Early-Onset CRC
- Ryan Quigley
- Christopher Cann, MD
Oncogenic Drivers in Never-Smokers with NSCLC
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®
Oncogenic Drivers in Never-Smokers with NSCLC
- Apar Kishor Ganti, MD, MS
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
- Brian P. McDonough, MD, FAAFP
- Tara Graff, DO, MS
- Surbhi Sidana, MD